However, consistent with our CRISPR Activatory Screen (Fig. 1D), protein expression of antiapoptotic MCL-1 was significantly associated with resistance to MEDI3039 in the colorectal cancer panel (Spearman r = −0.73, P = 0.008; Supplementary Fig. S3C). Here, MCL1 is linked to colorectal cancer.